A 3.5% dividend yield and a long track record of dividend increases have turned PepsiCo Inc.(NASDAQ:PEP) into a core holding for many income investors, but Pepsi isn’t the only big company that’s paying a market-beating dividend. In fact, other companies may offer investors a better blend of potential price appreciation and dividends than it does. To help you find those stocks, we asked three Motley Fool contributors to offer up companies they like more than Pepsi. Read on to find out why they think Pepsi lovers ought to consider TerraForm Power(NASDAQ:TERP), AstraZeneca. (NYSE:AZN), and Royal Dutch Shell (NYSE:RDS-A)(NYSE:RDS-B) instead.
Marijuana stocks have been on fire lately, with investors looking at the rising tide of new jurisdictions in which marijuana is becoming legal for recreational use. With the entire nation of Canada legalizing recreational cannabis later this month, the companies that will provide the marijuana that users want to smoke see a potential gold mine ahead.
Is your goal to get rich? There’s lots of advice out there about how to do it, and a lot of it centers on spending less so you can save more.
Canada’s Tilray (NASDAQ:TLRY), a marijuana cultivator and distributor, has given early investors the ride of their lives since going public last June. Last week, for instance, the company’s stock peaked at exactly $300 per share, representing a jaw-dropping 856% gain for the brave souls that bought this speculative IPO right off the bat.
Every investor wants the kind of stock you can buy and forget about. These are the kinds of stocks that will rack up giant returns over time as their competitive advantages accrue, much as the FANG group of stocks has over the last decade. They often operate in timeless businesses that are insulated from broader changes in technology or consumer tastes.
You don’t get a second chance to make a first impression, and it’s safe to say that Sonos(NASDAQ:SONO) didn’t get it right the first time. The maker of high-end wireless speakers has seen its stock plummet 22% over the past four trading days, taking a hit after its first quarterly report as a public company failed to impress the market.
There’s a growing epidemic in the U.S. and other developed nations and there aren’t any available treatments to tackle the problem. Right now, nonalcoholic steatohepatitis (NASH) is damaging around 20 million livers in the U.S., and it’s quickly becoming the No. 1 reason to join a transplant waitlist.
Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), Madrigal Pharmaceuticals Inc.(NASDAQ:MDGL), and Gilead Sciences Inc. (NASDAQ:GILD) are three top stocks for investing this arena, which could be worth as much as $35 billion annually by 2020. There are plenty of companies with NASH candidates, but these three biotechs rise to the top of the list for some very different reasons.
The gaming industry may not be the first place you would look for dividend stocks, but it has some surprisingly strong dividends right now. Las Vegas Sands (NYSE:LVS), Wynn Resorts(NASDAQ:WYNN), and Melco Resorts (NASDAQ:MLCO) all have strong cash flows and solid dividend yields for investors.
If you want to take the pulse of the North American oil and gas market, one of the best places to start is Halliburton‘s (NYSE:HAL) quarterly conference call. As the largest oil services company in North America and with clients of all sizes across every shale basin, management has an intimate knowledge of what is going on in the oil patch at any given moment. Listening to, or reading a transcript of, Halliburton’s quarterly conference calls can give investors insights into the market that can help steer investment decisions.
Over the last five years, the S&P 500 index has returned around 87%, including reinvested dividends, a decent performance by any measure. Yet investors could have done much better investing in any number of individual stocks, and it wouldn’t have required taking fliers on risky penny stocks, either.